相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?
Noriaki Fukuhara et al.
ENDOCRINE PATHOLOGY (2021)
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
Olivera Casar-Borota et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing
Antonella Sesta et al.
NEUROENDOCRINOLOGY (2020)
Pangenomic Classification of Pituitary Neuroendocrine Tumors
Mario Neou et al.
CANCER CELL (2020)
A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
Derya Metin-Armagan et al.
ENDOCRINE PATHOLOGY (2020)
Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors
Mujdat Kara et al.
ENDOCRINE PATHOLOGY (2020)
Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly
Lisa B. Nachtigall et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion
Ryota Tamura et al.
ENDOCRINE PATHOLOGY (2019)
Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma
Lilla Krokker et al.
NEUROCHEMICAL RESEARCH (2019)
Histologic, immunohistochemical, and molecular features of pituicytomas and atypical pituicytomas
Angela N. Viaene et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome
Michal Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The Genomic Landscape of Sporadic Prolactinomas
Sunita M. C. De Sousa et al.
ENDOCRINE PATHOLOGY (2019)
Hypothalamic Endocrine Tumors: An Update
Sylvia L. Asa et al.
JOURNAL OF CLINICAL MEDICINE (2019)
PREDICTIVE MARKERS FOR POSTSURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE
Shereen Ezzat et al.
ENDOCRINE PRACTICE (2019)
Succinate dehydrogenase (SDH)-deficient neoplasia
Anthony J. Gill
HISTOPATHOLOGY (2018)
Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas
Mirella Hage et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Epidemiology and biomarker profile of pituitary adenohypophysial tumors
Ozgur Mete et al.
MODERN PATHOLOGY (2018)
Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications
Shereen Ezzat et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Identification of recurrent USP48 and BRAF mutations in Cushing's disease
Jianhua Chen et al.
NATURE COMMUNICATIONS (2018)
Identification of Novel Genes Involved in the Pathogenesis of an ACTH-Secreting Pituitary Carcinoma: A Case Report and Literature Review
Fuyou Guo et al.
FRONTIERS IN ONCOLOGY (2018)
USP8 Mutations in Pituitary Cushing Adenomas-Targeted Analysis by Next-Generation Sequencing
Cora Ballmann et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Landscape of Genomic Alterations in Pituitary Adenomas
Wenya Linda Bi et al.
CLINICAL CANCER RESEARCH (2017)
FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors
Shereen Ezzat et al.
ONCOTARGET (2017)
MEN4 and CDKN1B mutations: the latest of the MEN syndromes
Rami Alrezk et al.
ENDOCRINE-RELATED CANCER (2017)
Pituitary acromegaly: not one disease
Sylvia L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
Daniel Bengtsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy
Elham Rostami et al.
ACTA NEUROCHIRURGICA (2017)
The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
Kyohei Hayashi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K. Brastianos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
Priscilla K. Brastianos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells
Thomas Cuny et al.
ENDOCRINE-RELATED CANCER (2016)
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas
Ozgur Mete et al.
MODERN PATHOLOGY (2016)
MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma
Michael B. Miller et al.
ONCOTARGET (2016)
Recurrent gain-of-function USP8 mutations in Cushing's disease
Zeng-Yi Ma et al.
CELL RESEARCH (2015)
ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice
Xiaohai Liu et al.
ENDOCRINOLOGY (2015)
STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion
Cuiqi Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
FGFR1 and PROKR2 rare variants found in patients with combined pituitary hormone deficiencies
Fernanda A. Correa et al.
ENDOCRINE CONNECTIONS (2015)
Breast cancer risk in MEN1-a cancer genetics perspective
Paul Brennan
CLINICAL ENDOCRINOLOGY (2015)
Mutations in the deubiquitinase gene USP8 cause Cushing's disease
Martin Reincke et al.
NATURE GENETICS (2015)
Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations
Leanne de Kock et al.
ACTA NEUROPATHOLOGICA (2014)
Germline and Somatic DICER1 Mutations in a Pituitary Blastoma Causing Infantile-Onset Cushing's Disease
Taninee Sahakitrungruang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Rajesh V. Thakker
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
FGFR4 Polymorphic Variants Modulate Phenotypic Features of Cushing Disease
Tae Nakano-Tateno et al.
MOLECULAR ENDOCRINOLOGY (2014)
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
Priscilla K. Brastianos et al.
NATURE GENETICS (2014)
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
G. Trivellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spindle Cell Oncocytomas and Granular Cell Tumors of the Pituitary Are Variants of Pituicytoma
Ozgur Mete et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Albert Beckers et al.
ENDOCRINE REVIEWS (2013)
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
Sarah Larkin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Whole-Exome Sequencing Studies of Nonfunctioning Pituitary Adenomas
Paul J. Newey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?
Paraskevi Xekouki et al.
ENDOCRINE-RELATED CANCER (2012)
The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
Toru Tateno et al.
PLOS GENETICS (2011)
The effect of polymorphisms in the promoter region of the MMP-1 gene on the occurrence and invasiveness of hypophyseal adenoma
Murat Altas et al.
ACTA NEUROCHIRURGICA (2010)
MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27Kip1 and p18INK4C) mutations
Marianthi Georgitsi
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae
Yuriz Bakhtiar et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Pathogenesis of Pituitary Tumors
Sylvia L. Asa et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
被撤回的出版物: HMGA Proteins Up-regulate CCNB2 Gene in Mouse and Human Pituitary Adenomas (Retracted article. See vol. 78, pg. 6906, 2018)
Ivana De Martino et al.
CANCER RESEARCH (2009)
P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease
Sachiko-Tsukamoto Kawashima et al.
CLINICAL ENDOCRINOLOGY (2009)
Rare Germline Mutations in Cyclin-Dependent Kinase Inhibitor Genes in Multiple Endocrine Neoplasia Type 1 and Related States
Sunita K. Agarwal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
Zhi Rong Qian et al.
MODERN PATHOLOGY (2009)
Pituitary blastoma
Bernd W. Scheithauer et al.
ACTA NEUROPATHOLOGICA (2008)
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): A case-control study in a series of 77 patients versus 2509 non-MEN1 patients
Jacqueline Trouillas et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia
Xuegong Zhu et al.
CLINICAL CANCER RESEARCH (2008)
Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas
Marianthi Georgitsi et al.
CLINICAL ENDOCRINOLOGY (2008)
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident
Angel Cecilia Pesatori et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells
Xuegong Zhu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pituitary-specific knockout of the carney complex gene Prkar1a leads to pituitary tumorigenesis
Zhirong Yin et al.
MOLECULAR ENDOCRINOLOGY (2008)
Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses
Chheng-Orn Evans et al.
PITUITARY (2008)
Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas
Koji Morita et al.
CLINICAL ENDOCRINOLOGY (2008)
P53 gene mutations in pituitary carcinomas
Yoshinori Tanizaki et al.
ENDOCRINE PATHOLOGY (2007)
The clinical, pathological, and genetic features of familial isolated pituitary adenomas
Albert Beckers et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors
Sylvia L. Asa et al.
CANCER RESEARCH (2007)
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia
Marianthi Georgitsi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells
Xuegong Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Targeting N-cadherin through fibroblast growth factor receptor-4: Distinct pathogenetic and therapeutic implications
Shereen Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2006)
Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells
Shereen Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2006)
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Natalia S. Pellegata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity
Monica Fedele et al.
CANCER CELL (2006)
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
Outi Vierimaa et al.
SCIENCE (2006)
Mechanisms of disease: the pathogenesis of pituitary tumors
S Ezzat et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growth
S Ezzat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
β-catenin mutations in craniopharyngiomas and pituitary adenomas
E Oikonomou et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region
R Buslei et al.
ACTA NEUROPATHOLOGICA (2005)
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell
M Fedele et al.
ONCOGENE (2005)
Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice
A Lasorella et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors
J Zhao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility
S Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2005)
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: Relation to tumor type, size, proliferation, and invasiveness
ZR Qian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation
A Bahar et al.
ONCOGENE (2004)
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia
S Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2004)
Isolation and characterization of a novel pituitary tumor apoptosis gene
A Bahar et al.
MOLECULAR ENDOCRINOLOGY (2004)
Evolution of the Fgf and Fgfr gene families
N Itoh et al.
TRENDS IN GENETICS (2004)
Pituitary tumor AP-2α recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4
SJ Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ARF mutation accelerates pituitary tumor development in Rb± mice
KY Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Craniopharyngiomas of adamantinomatous type harbor β-catenin gene mutations
S Sekine et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas
M Fedele et al.
ONCOGENE (2002)
Development - Pituitary development: Regulatory codes in mammalian organogenesis
KM Scully et al.
SCIENCE (2002)
Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice
SL Asa et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex
LS Kirschner et al.
NATURE GENETICS (2000)
分享论文
